MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on December 13, 2007; DOI: 10.1124/mol.107.042481


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.042481v1
mol.107.042481v2
73/3/960    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Author home page(s):
J. Michael Edwardson
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barrera, N. P
Right arrow Articles by Edwardson, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barrera, N. P
Right arrow Articles by Edwardson, J. M.


Received for publication October 4, 2007.
Revised December 11, 2007.
Accepted for publication December 12, 2007.

Atomic force microscopy reveals the stoichiometry and subunit arrangement of the {alpha}4{beta}3{delta} GABAA receptor

Nelson P Barrera 1, Jill Betts 1, Haitao Yao 2, Robert M Henderson 1, Ian L Martin 3, Susan MJ Dunn 2, J. Michael Edwardson 1*

1 University of Cambridge 2 University of Alberta 3 Aston University

* Address correspondence to: E-mail: jme1000{at}cam.ac.uk

Abstract

The GABAA receptor is a chloride-selective ligand-gated ion channel of the Cys-loop superfamily. The receptor consists of five subunits arranged pseudosymmetrically around a central pore. The predominant form of the receptor in the brain contains {alpha}1-, {beta}2-, and {gamma}2-subunits in the arrangement {alpha}{beta}{alpha}{gamma}{beta}, counter-clockwise around the pore. GABAA receptors containing {delta}- instead of {gamma}-subunits, although a minor component of the total receptor population, have interesting properties, such as an extrasynaptic location, high sensitivity to GABA and potential association with conditions such as epilepsy. They are therefore attractive targets for drug development. Here we addressed the subunit arrangement within the {alpha}4{beta}3{delta} form of the receptor. Different epitope tags were engineered onto the three subunits, and complexes between receptors and anti-epitope antibodies were imaged by atomic force microscopy. Determination of the numbers of receptors doubly decorated by each of the three antibodies revealed a subunit stoichiometry of 2{alpha}:2{beta}:1{delta}. The distributions of angles between pairs of antibodies against the {alpha}- and {beta}-subunits both had peaks at around 144°, indicating that these pairs of subunits were non-adjacent. Decoration of the receptor with ligands that bind to the extracellular domain (i.e. the lectin concanavalin A and an antibody that recognizes the {beta}-subunit N-terminal sequence) showed that the receptor preferentially binds to the mica extracellular face down. Given this orientation, the geometry of complexes of receptors with both an antibody against the {delta}-subunit and Fab fragments against the {alpha}-subunits indicates a predominant subunit arrangement of {alpha}{beta}{alpha}{delta}{beta}, counter-clockwise around the pore when viewed from the extracellular space.


Key words: GABAA, GABAC, Structure determinations


This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
R. W. Olsen and W. Sieghart
International Union of Pharmacology. LXX. Subtypes of {gamma}-Aminobutyric AcidA Receptors: Classification on the Basis of Subunit Composition, Pharmacology, and Function. Update
Pharmacol. Rev., September 1, 2008; 60(3): 243 - 260.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics